Literature DB >> 29791289

Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy.

Daniel J Boffa1, Andrzej S Kosinski1, Anthony P Furnary1, Sunghee Kim1, Mark W Onaitis1, Betty C Tong1, Patricia A Cowper1, Jessica R Hoag1, Jeffrey P Jacobs1, Cameron D Wright1, Joe B Putnam1, Felix G Fernandez1.   

Abstract

Purpose The prevalence of minimally invasive lung cancer surgery using video-assisted thoracic surgery (VATS) has increased dramatically over the past decade, yet recent studies have suggested that the lymph node evaluation during VATS lobectomy is inadequate. We hypothesized that the minimally invasive approach to lobectomy for stage I lung cancer resulted in a longitudinal outcome that was not inferior to thoracotomy. Patients and Methods Patients > 65 years of age who had undergone lobectomy for stage I lung cancer between 2002 and 2013 were analyzed within the Society of Thoracic Surgeons General Thoracic Surgery Database, which had been linked to Medicare data, as part of a retrospective-cohort, noninferiority study. Results A total of 10,597 patients with clinical stage I lung cancer who underwent lobectomy were evaluated (4,448 patients underwent thoracotomy, and 6,149 underwent VATS). VATS patients had a more favorable distribution of all health-related variables, including pulmonary function (59% of VATS patients had intact spirometry v 51% of thoracotomy patients; P < .001). Cox proportional hazards models were performed over two eras to account for an evolving practice standard. The mortality risk associated with the VATS approach was not greater than thoracotomy in either the earlier era (2002 to 2008; hazard ratio, 0.97; 95% CI, 0.87 to 1.09; P = .62) or the more recent era (2009 to 2013; hazard ratio, 0.84; 95% CI, 0.75 to 0.93; P < .001). Kaplan-Meier survival estimates of 2,901 propensity-matched VATS-thoracotomy pairs demonstrated that the 4-year survival associated with VATS (68.6%) was modestly superior to thoracotomy (64.8%; P = .003). The analyses detailed above were replicated in a separate cohort of pathologic stage I patients with similar findings. Conclusion The long-term efficacy of lobectomy for stage I lung cancer performed using the VATS approach by board-certified thoracic surgeons does not seem to be inferior to that of thoracotomy.

Entities:  

Mesh:

Year:  2018        PMID: 29791289     DOI: 10.1200/JCO.2018.77.8977

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  17 in total

1.  Minimally invasive thoracic surgery in lung cancer: respecting oncologic principles is the key.

Authors:  Diego Gonzalez-Rivas; William Guido-Guerrero; Albert Bolaños-Cubillo
Journal:  Ann Transl Med       Date:  2018-12

2.  Oncologic validity of minimally invasive lobectomy for early stage lung cancer.

Authors:  Todd L Demmy; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 3.  Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery.

Authors:  Shugeng Gao; Serena Barello; Liang Chen; Chun Chen; Guowei Che; Kaican Cai; Roberto Crisci; Antonio D'Andrilli; Andrea Droghetti; Xiangning Fu; Paolo Albino Ferrari; Hiran C Fernando; Di Ge; Guendalina Graffigna; Yunchao Huang; Jian Hu; Wenjie Jiao; Gening Jiang; Xiaofei Li; Hui Li; Shanqing Li; Lunxu Liu; Haitao Ma; Dongchun Ma; Guillermo Martinez; Giulio Maurizi; Kevin Phan; Kun Qiao; Majed Refai; Erino A Rendina; Guoguang Shao; Jianfei Shen; Hui Tian; Luca Voltolini; Jacopo Vannucci; Camilla Vanni; Qingchen Wu; Shidong Xu; Fenglei Yu; Song Zhao; Peng Zhang; Lanjun Zhang; Xiuyi Zhi; Chengchu Zhu; Calvin Ng; Alan D L Sihoe; Anthony M H Ho
Journal:  Transl Lung Cancer Res       Date:  2019-12

4.  Comparison of post-operative pain and quality of life between uniportal subxiphoid and intercostal video-assisted thoracoscopic lobectomy.

Authors:  Jian Chen; Sara Volpi; Jason M Ali; Giuseppe Aresu; Liang Wu; Zhigang Chen; Jin Wang; Bei Chen; Chenlu Yang; Kostis Marios Soultanis; Gening Jiang; Lei Jiang
Journal:  J Thorac Dis       Date:  2020-07       Impact factor: 2.895

5.  Mortality for Robotic- vs Video-Assisted Lobectomy-Treated Stage I Non-Small Cell Lung Cancer Patients.

Authors:  Yong Cui; Eric L Grogan; Stephen A Deppen; Fei Wang; Pierre P Massion; Christina E Bailey; Wei Zheng; Hui Cai; Xiao-Ou Shu
Journal:  JNCI Cancer Spectr       Date:  2020-04-15

6.  Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume Center.

Authors:  Chengwu Liu; Chenglin Guo; Fanyi Gan; Jiandong Mei; Qiang Pu; Zheng Liu; Yunke Zhu; Hu Liao; Lin Ma; Feng Lin; Lunxu Liu
Journal:  Surg Endosc       Date:  2020-05-11       Impact factor: 4.584

7.  Comparison of lymph node dissection and lymph node sampling for non-small cell lung cancers by video-assisted thoracoscopic surgery.

Authors:  Weigang Zhao; Tangbing Chen; Jian Feng; Zhitao Gu; Zhexin Wang; Chunyu Ji; Wentao Fang
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

8.  Comparison of robotic-assisted lobectomy with video-assisted thoracic surgery for stage IIB-IIIA non-small cell lung cancer.

Authors:  Chongwu Li; Yingjie Hu; Jia Huang; Jiantao Li; Long Jiang; Hao Lin; Peiji Lu; Qingquan Luo
Journal:  Transl Lung Cancer Res       Date:  2019-12

9.  Comparative Effectiveness of Surgical Approaches for Lung Cancer.

Authors:  Adwaiy Manerikar; Melissa Querrey; Emily Cerier; Samuel Kim; David D Odell; Lorenzo L Pesce; Ankit Bharat
Journal:  J Surg Res       Date:  2020-12-09       Impact factor: 2.417

10.  Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.

Authors:  Shibin Du; Jian-Zhi Yang; Jing Chen; Wei-Gang Zhou; Yan-Yan Sun
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.